Optiscan Imaging (OIL) Stock Price, News & Analysis

Company Overview

Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, and Internationally. It offers InVivage, an intra-oral digital hand-held confocal endomicroscope for oral cancer screening and/or surgical margin determination; and ViewnVivo, a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging. The company has a collaboration agreement with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system for applications in robotic surgery. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 77,463 shs
• Average Volume: N/A
• Market Capitalization: $129.48 million
• P/E Ratio: N/A
• Dividend Yield: 4.29%
• Price Target: N/A
• Consensus Rating: N/A

OIL Stock Analysis - Frequently Asked Questions

How were Optiscan Imaging's earnings last quarter?

Optiscan Imaging Limited (ASX:OIL) posted its quarterly earnings results on Thursday, February, 28th. The company reported $0.00 earnings per share for the quarter. Optiscan Imaging had a negative trailing twelve-month return on equity of 40.05% and a negative net margin of 230.34%.

What other stocks do shareholders of Optiscan Imaging own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Optiscan Imaging investors own include Brookside Energy (BRK), (FIRE.V) (FIRE) and Core Lithium (CXO).

Company Calendar

• Last Earnings: 2/28/2019
• Today: 3/25/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Computer and Technology
• Industry: Scientific & Technical Instruments
• Sub-Industry: Banking
• Current Symbol: ASX:OIL
• CIK: N/A
• Web: www.optiscan.com
• Phone: 61 3 9538 3333
• Fax: N/A
• Employees: 2,020
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-6,060,000.00
• Net Margins: -230.34%
• Pretax Margin: N/A
• Return on Equity: -40.05%
• Return on Assets: -40.54%

Debt

• Debt-to-Equity Ratio: 1.59
• Current Ratio: 8.59
• Quick Ratio: 5.94

Sales & Book Value

• Annual Sales: $2.99 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 43.00
• Book Value: A$0.02 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 835,340,000
• Free Float: N/A
• Market Cap: $129.48 million
• Optionable: Not Optionable
• Beta: 1.20